CERENOME, INC.
Income Statement
| Line Item | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|
| Revenue | $7.1M | $8.7M | $8.0M | $8.3M | $5.8M |
| Cost of Revenue | $3.4M | $4.0M | $3.8M | $3.9M | $3.4M |
| Gross Profit | $3.7M | $4.7M | $4.1M | $4.3M | $2.4M |
| Gross Margin | 52.0% | 54.1% | 51.9% | 52.7% | 41.9% |
| Operating Expenses | |||||
| Research & Development | $17.1M | $13.6M | $10.9M | $9.7M | $12.2M |
| SG&A Expense | $16.0M | $15.7M | $14.7M | $12.6M | $10.4M |
| Operating Income | $-30.7M | $-28.4M | $-29.4M | $-25.3M | $-21.5M |
| Operating Margin | -430.8% | -326.3% | -368.4% | -306.8% | -369.1% |
| Interest Expense | $3.4M | $3.4M | $2.8M | $2.1M | $1.4M |
| Pretax Income | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — |
| Net Income | $-26.2M | $-32.3M | $-32.5M | $-27.5M | $-23.2M |
| Net Margin | -367.6% | -370.6% | -406.5% | -333.1% | -397.7% |
| EPS (Basic) | $-0.02 | $-0.03 | $-0.03 | $-0.03 | — |
| EPS (Diluted) | $-0.02 | $-0.03 | $-0.03 | $-0.03 | $-0.03 |
| Shares Outstanding (Basic) | 1.43B | 1.32B | — | — | — |
| Shares Outstanding (Diluted) | 1.43B | 1.32B | 1.07B | 919.0M | 718.8M |
| Dividends Per Share | — | — | — | — | — |